Latest News from: Cancer Research Institute

Filters close
Newswise: New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer
Released: 24-Jan-2024 8:50 AM EST
New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer
Cancer Research Institute

CRI helped commission a poll of oncologists who say that much more research is required to holistically tackle non-small cell lung cancer.

Newswise: Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell
Released: 19-Dec-2023 10:15 AM EST
Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell
Cancer Research Institute

The Cancer Research Institute and Lance Kawaguchi with the #SouthPoleTrek4Cancer ring in the Nasdaq Stock Market Closing Bell.

Newswise: The Cancer Research Institute’s Patient Immunotherapy Summit is Now Available On Demand
Released: 6-Dec-2023 1:30 PM EST
The Cancer Research Institute’s Patient Immunotherapy Summit is Now Available On Demand
Cancer Research Institute

CRI's 2023 Patient Immunotherapy Summit is now available on-demand for the benefit of cancer patients, families, caregivers, and scientists.

Newswise: Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award
Released: 27-Oct-2023 2:45 PM EDT
Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award
Cancer Research Institute

The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.

Released: 11-Oct-2023 3:25 PM EDT
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of a Project Grant
Cancer Research Institute

Michael Berger, PhD, has been awarded a grant by The Israel Cancer Research Fund (ICRF) and the Cancer Research Institute (CRI).

Newswise: The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 
Released: 18-Sep-2023 9:00 AM EDT
The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 
Cancer Research Institute

The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 

Released: 19-Jul-2023 1:00 PM EDT
Cancer Research Institute Awards Over $28 Million in Grants to Fuel Immunotherapy Innovations
Cancer Research Institute

The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.

Newswise: Fern Lazar of FINN Partners Joins Board of Trustees at the Cancer Research Institute
Released: 12-Jul-2023 8:00 AM EDT
Fern Lazar of FINN Partners Joins Board of Trustees at the Cancer Research Institute
Cancer Research Institute

Fern Lazar, Managing Partner and Global Health Practice Leader at FINN Partners, was elected to the Cancer Research Institute’s Board of Trustees.

Newswise: Cancer Research Institute to Honor Dr. Tak Mak with 2023 William B. Coley Award
Released: 7-Jun-2023 11:00 AM EDT
Cancer Research Institute to Honor Dr. Tak Mak with 2023 William B. Coley Award
Cancer Research Institute

The Cancer Research Institute is honoring Dr. Tak Mak with the prestigious 2023 William B. Coley Award.

Released: 18-Apr-2023 3:05 PM EDT
Immunotherapy Drug Development Pipeline Shifts from Traditional Therapies to Newer Modalities
Cancer Research Institute

The immuno-oncology (IO) clinical trial landscape is shifting in new directions. While the number of total clinical trials is down, there are healthy signs of innovation.

Released: 15-Mar-2023 3:25 PM EDT
Cancer Research Institute Named Beneficiary of South Pole Trek
Cancer Research Institute

Lance Kawaguchi, an internationally recognized executive leader and board member with over 25 years of global finance and banking experience, will be undertaking a monumental Trek to the South Pole in December 2023 to raise funds for several charities, including the Cancer Research Institute (CRI). Serving as a strategic advisor, he has pledged to lead a global effort to raise awareness and funds for CRI.

Released: 26-Oct-2022 2:45 PM EDT
Cancer Research Institute to Host Annual Virtual Immunotherapy Patient Summit on November 11-12, 2022
Cancer Research Institute

Free online event for cancer patients and caregivers featuring immunotherapy experts and patient advocates taking place Nov. 11-12, 2022.

Released: 11-Oct-2022 8:00 AM EDT
Cancer Research Institute and Israel Cancer Research Fund Announce Co-Funding of a Translational Immunotherapy Research Grant
Cancer Research Institute

The CRI-ICRF Clinic and Laboratory Integration Program (CLIP) Grant to Fund Promising Immunotherapy Research in Israel Is Awarded to Yifat Merbl, PhD, of the Weizmann Institute of Science.

Released: 30-Sep-2022 6:05 PM EDT
Cancer Research Institute to Honor Scientists for Groundbreaking Discoveries Leading to New Immune-Based Strategies That Target Gasdermins in Cancer Treatment
Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the immune system’s power to control and potentially cure all types of cancer, will confer its prestigious 2022 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology on four scientists for their collective work that revealed the role of the pore-forming gasdermins in pyroptosis and promotion of anti-tumor immunity, setting the stage for targeting gasdermins in cancer therapeutics.

Released: 6-Sep-2022 4:45 PM EDT
El Cancer Research Institute Presentará La Segunda Conferencia Virtual en Español Cri De Inmunoterapia Para Pacientes Con Cáncer, Moderada Por Ana Patricia Gámez, Quien Compartirá Información Vital Para La Comunidad Hispana, Pacientes Y Sus Familias
Cancer Research Institute

El Cancer Research Institute (CRI), una organización sin fines de lucro consagrada a aprovechar la capacidad del sistema inmunitario para combatir y potencialmente curar todos los tipos de cáncer, ofrecerá su segunda Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer, el 22 de septiembre de 2022, de 2 a 5 p. m. (hora del este).

Released: 6-Sep-2022 4:45 PM EDT
Cancer Research Institute to Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated by Ana Patricia Gámez, to Connect the U.S. Hispanic Cancer Community with Information That Can Save Lives
Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET.

Released: 22-Jun-2022 1:20 PM EDT
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
Cancer Research Institute

Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with the potential to transform cancer treatment

Released: 1-Jun-2022 10:05 AM EDT
Cellular Cancer Immunotherapy Clinical Development Continues to Evolve and Expand with Novel Technologies and Targets, New Report From Cancer Research Institute Shows
Cancer Research Institute

Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends and real-world usage, highlights key challenges including effective solid tumor targeting, manufacturing complexities, and commercial access to approved therapies

Newswise: Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
Released: 10-Feb-2022 9:10 AM EST
Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
Cancer Research Institute

A new report from the Cancer Research Institute on the global landscape of PD1/PDL1 immunotherapy clinical development

Released: 4-Nov-2021 8:00 AM EDT
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering: “This Technology Will Play a Big Role in Cancer Treatment”
Cancer Research Institute

CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.

Released: 1-Oct-2021 8:35 AM EDT
CRI Immunotherapy Summit Grows Along with Cancer Treatment Prospects - Virtual Gathering of Patients, Experts Hosted by Tamron Hall: “Happens Nowhere Else”
Cancer Research Institute

CRI's Online Immunotherapy Patient Summit connects cancer patients and caregivers to scientific and medical experts, explores clinical trials, cancer care disparities

Released: 23-Aug-2021 12:30 PM EDT
Ana Patricia Gámez se une al Cancer Research Institute en su compromiso por la igualdad racial en el cuidado de la salud, como presentadora de la primera Conferencia Virtual en Español Sobre Inmunoterapia Contra el Cáncer
Cancer Research Institute

El Cancer Research Institute (CRI), organización sin fines de lucro liderando investigación revolucionaria sobre el poder de nuestro sistema inmunológico para controlar y potencialmente curar todos los tipos de cáncer, ofrecerá su primera Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer 2021 totalmente en español, el 16 de septiembre de 2021, de 2 a 5 p.m. (hora del este).

Released: 23-Aug-2021 12:05 PM EDT
Ana Patricia Gámez Joins Cancer Research Institute in the Movement for Racial Health Equity, Named Moderator of First Spanish-Language Virtual Cancer Immunotherapy Summit
Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system’s power to control and potentially cure all cancers, will offer its first-ever Virtual Cancer Immunotherapy Summit in Spanish on September 16, 2021, 2-5 p.m. ET.

Released: 22-Jul-2021 8:00 AM EDT
Cancer Research Institute Awards $28.5 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy
Cancer Research Institute

Cancer Research Institute announced grants and fellowships of $28.5 million to scientists advancing immunology and cancer immunotherapy research

Released: 22-Jul-2021 8:00 AM EDT
Cancer Research Institute Announces First Recipients of the New CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
Cancer Research Institute

Cancer Research Institute announces first recipients of new fellowship program designed to promote racial diversity and inclusion in immunology and tumor immunology

Released: 25-Jun-2021 8:00 AM EDT
El Cancer Research Institute Lanza Su Website Como Centro De InformacióN en EspañOl, en Su Compromiso De Liderar El Cambio Por La Igualdad Racial en El Cuidado De La Salud
Cancer Research Institute

El Cancer Research Institute anunció hoy que ha lanzado su primer website en español para conectar a los pacientes hispanos y sus cuidadores con la información más reciente sobre la inmunoterapia contra el cáncer y las opciones de tratamiento.

Released: 25-Jun-2021 8:00 AM EDT
Cancer Research Institute (CRI) Launches Spanish-Language Resource Hub in Its Commitment to Lead the Change in Racial Health Equity
Cancer Research Institute

The Cancer Research Institute (CRI) announced today that is has launched its first-ever Spanish-language information hub to connect Hispanic patients and caregivers with the latest cancer immunotherapy research and treatment options.

Released: 25-May-2021 7:00 PM EDT
Cancer Research Institute Celebrates Ninth Annual Cancer Immunotherapy Month™
Cancer Research Institute

Cancer Research Institute celebrates progress in cancer immunotherapy research, announces new initiatives aimed at addressing racial and ethnic disparities in cancer treatment and academic research, during ninth annual Cancer Immunotherapy Month this June.

   
Released: 11-Nov-2020 4:00 PM EST
Cancer Research Institute CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey Receives Inaugural Tara Withington Public Service Award from the Society for Immunotherapy of Cancer
Cancer Research Institute

Award honors individuals and organizations that foster and enhance the field of cancer immunotherapy through increasing public understanding, awareness, research efforts, and/or funding

Released: 11-Nov-2020 11:35 AM EST
Combination Drug Strategies Gain Ground in Global Immuno-Oncology Pipeline of PD-1 and PD-L1 Clinical Trials, New Report from Cancer Research Institute Reveals
Cancer Research Institute

Analysis update by the nonprofit Cancer Research Institute reveals dramatic growth in PD-1/PD-L1 monoclonal antibody combination cancer treatment strategies in global clinical trial pipeline

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 4:45 PM EDT
Cancer Research Institute Goes Virtual for Its Immunotherapy Patient Summit Series, Connecting Patients and Caregivers with Leading Experts in Cancer Immunotherapy
Cancer Research Institute

Free virtual event October 2-3 connecting cancer patients and caregivers with leading immunotherapy experts and patient advocates treated with immunotherapy

Released: 10-Sep-2020 7:00 AM EDT
Cancer Research Institute Announces Recipients of 2020 Philanthropy and Science Awards to Be Presented at Virtual Gala, Innovators in Science and Philanthropy
Cancer Research Institute

Honorees recognized for supporting and making significant scientific advancements in cancer immunotherapy research to help create better treatment options for cancer patients

Released: 5-Aug-2020 2:00 PM EDT
Cancer Research Institute Awards $30.2 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy
Cancer Research Institute

The Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, awarded more than $30.2 million in research grants and fellowships in the 2020 fiscal year ending June 30, 2020.

Released: 1-Jun-2020 11:40 AM EDT
Eighth Annual Cancer Immunotherapy Month™ in June Celebrates Progress in Treatment and Advances in Research
Cancer Research Institute

June is Cancer Immunotherapy Month, a 30-day awareness campaign started by the Cancer Research Institute eight years ago to educate, inform, and inspire the global community of patients, caregivers, scientists, donors, and other cancer-concerned individuals and organizations.

Released: 26-May-2020 9:00 AM EDT
Rapid Growth in Global Development of Cancer Cellular Immunotherapies Highlighted by Latest Report from Cancer Research Institute and GlobalData
Cancer Research Institute

A new report, published in Nature Reviews Drug Discovery, reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago

Released: 18-May-2020 10:05 AM EDT
Cancer Research Institute and IQVIA Uncover the Impact of COVID-19 Pandemic on Global Oncology Clinical Trials
Cancer Research Institute

New study reveals impact of COVID-19 pandemic on cancer clinical trials, published in Nature Reviews Drug Discovery

Released: 4-Nov-2019 11:00 AM EST
Updated Report on Trends in Global PD-1/PD-L1 Immunotherapy Clinical Development from the Cancer Research Institute Published in Nature Reviews Drug Discovery
Cancer Research Institute

Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to China.

Released: 27-Sep-2019 5:05 AM EDT
Latest Global Immuno-Oncology Landscape Report from the Cancer Research Institute Published in Nature Reviews Drug Discovery
Cancer Research Institute

Cancer Research Institute analysis of the global immuno-oncology landscape shows dramatic two-year growth in therapeutic targets and I-O drugs in clinical development

Released: 26-Sep-2019 2:00 AM EDT
Cancer Research Institute Announces 2019 Recipients of Its Top Scientific and Philanthropic Awards Honoring Discovery, Service in AdvancingCancer Immunology and Immunotherapy Research
Cancer Research Institute

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards. CRI will present the awards to ten honorees at its annual gala taking place Monday, October 7, 2019, at The Rainbow Room in New York City.

Released: 28-Jun-2019 10:00 AM EDT
Cancer Research Institute and Chordoma Foundation Partner to Advance Immunotherapy Research in Rare Cancer
Cancer Research Institute

Two nonprofits team up to fund research aimed at discovering and developing immunotherapeutic approaches to treating chordoma, a rare type of bone cancer.

Released: 21-Jun-2019 10:00 AM EDT
Cancer Research Institute Hosts Inaugural “Immuno-Oncology: A Future Look” Media and Investor Event in New York City
Cancer Research Institute

The Cancer Research Institute (CRI) will host its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media today in New York City at the New York Academy of Sciences from 10:00 am – 12:00 pm ET.

Released: 21-Jun-2019 10:00 AM EDT
Cancer Research Institute Names New Stars of Cancer Immunotherapy Research
Cancer Research Institute

Five U.S. scientists have been awarded $1.25 million each from the Cancer Research Institute to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment

Released: 21-May-2019 3:00 PM EDT
Cancer Research Institute Champions Cancer Immunotherapy Month™ in June
Cancer Research Institute

The Cancer Research Institute announced today a series of public education and awareness offerings during its seventh annual Cancer Immunotherapy Month™ in June.

Released: 28-Nov-2018 9:00 AM EST
New Report Charts Dramatic Growth in the Global Clinical Trial Landscape for PD-1/L1 Immune Checkpoint Inhibitors
Cancer Research Institute

Latest Cancer Research Institute update on the landscape of anti-PD1/L1 checkpoint inhibitor clinical trials

Released: 19-Oct-2018 10:05 AM EDT
Updated Global Immuno-Oncology Landscape Report Highlights Robust International Pipeline Marked by Rapid Growth
Cancer Research Institute

The Cancer Research Institute has updated its analysis of the global immuno-oncology landscape, published today in Nature Reviews Drug Discovery.

   
Released: 10-Sep-2018 4:00 PM EDT
Three Scientists to Receive Top Honors From the Cancer Research Institute for Outstanding Contributions to Cancer Immunology and Immunotherapy
Cancer Research Institute

The Cancer Research Institute will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy at its annual taking place on Thursday, October 25, 2018, at The Metropolitan Club in New York City.

   
Released: 10-Sep-2018 4:00 PM EDT
Biotechnology Company Regeneron and Journalist and Filmmaker Perri Peltz to Receive the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research
Cancer Research Institute

he Cancer Research Institute will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its annual gala taking place on Thursday, October 25, 2018, at The Metropolitan Club in New York City.

   

Showing results 1 – 50 of 164


close
0.21928